Union Bancaire Privee’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$120M Buy
119,002
+14,158
+14% +$16.7M 1.16% 20
2026
Q2
$129M Buy
104,844
+3,612
+4% +$3.69M 1.41% 15
2026
Q1
$91M Buy
101,232
+16,934
+20% +$17.2M 1.27% 14
2025
Q4
$92.5M Sell
84,298
-3,199
-4% -$3.06M 1.1% 14
2025
Q3
$66.6M Buy
87,497
+4,173
+5% +$3.11M 0.95% 24
2025
Q2
$68M Buy
83,324
+5,118
+7% +$3.98M 0.99% 23
2025
Q1
$61.9M Buy
78,206
+11,484
+17% +$9.6M 1.19% 23
2024
Q4
$49.5M Buy
+66,722
New +$55.2M 0.86% 28

Other funds holding LLY

Union Bancaire Privee's LLY Position: Q3 2026 in Review

Union Bancaire Privee increased its Eli Lilly (LLY) stake by 14% in Q3 2026, buying an estimated $16.7M and bringing the position to 119,002 shares worth $120M. The position accounts for 1.16% of the portfolio, ranked #20.

Union Bancaire Privee first reported a position in LLY in Q4 2024 and has held it in 8 quarters since. The position peaked at $129M in Q2 2026. 4,616 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • Union Bancaire Privee held 119,002 shares of Eli Lilly worth $120M as of Q3 2026.
  • Union Bancaire Privee bought 14,158 Eli Lilly shares in Q3 2026, an estimated $16.7M.
  • Eli Lilly made up 1.16% of Union Bancaire Privee's portfolio in Q3 2026, its #20 holding.
  • Union Bancaire Privee first reported a position in Eli Lilly in Q4 2024 and has held it in 8 quarters since.
  • Union Bancaire Privee's Eli Lilly position peaked at $129M in Q2 2026.
  • 4,616 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on Union Bancaire Privee's 13F filing for Q3 2026, filed 4 Nov 2026.